Prader-Willi Syndrome Therapeutics Market: Is 2026 the First Year Families Live Without the "Shadow of Hunger"?
As of January 23, 2026, the prader-willi syndrome therapeutics market is identifying as one of the most dynamic rare disease sectors, with its 2026 valuation projected to reach approximately $575 million to $1.01 billion. The 2026 landscape is defined by a significant CAGR of up to 13.5% as the industry transitions from simple growth hormone management to life-altering hyperphagia treatments....
0 Commentaires 0 Parts 376 Vue 0 Aperçu